Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

Bayer is preparing to start a phase 3 trial of its cell therapy candidate bemdaneprocel for Parkinson's disease after ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in ...

Over more than eight years of monitoring, getting familiar with the EU CTR, conducting trial submissions activities, etc., ...

And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...

We’ll hear from speakers representing Syneos Health, Flagship Pioneering, and IPSEN on pharma dealmakers’ 2025 intentions, ...

But for an industry in which 46 recalls is 46 too many, given the potentially immense costs these incidents can exact, the ...

The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma ...

Each year at the JP Morgan Healthcare Conference, life sciences leaders congregate in San Francisco’s Union Square to network ...